MARKET

MBCOF

MBCOF

Marvel Biosciences Corp
OTCMQB
0.085
NaN%
Closed 09:30 10/26 EDT
OPEN
--
PREV CLOSE
0.085
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.170
52 WEEK LOW
0.074
MARKET CAP
6.26M
P/E (TTM)
-4.3265
1D
5D
1M
3M
1Y
5Y
1D
Broadcom's Risk Is Visible, Marvell's Isn't
Seeking Alpha · 10/15 07:26
Marvell: The Hidden $15 Billion AI Opportunity Nobody Should Ignore
Seeking Alpha · 10/13 09:03
Marvell Investor Day: Connectivity Lifts Outlook To $20 Billion
Seeking Alpha · 10/08 07:45
Marvel Biosciences Reports MB-204 as Highly Effective at Treating Autism Behaviours in Shank3 Mouse Model
Barchart · 10/08 05:45
Marvel Biosciences Signs Letter of Intent with Novatech for Phase 1 Trial of MB-204 and Provides Corporate Update
Barchart · 10/06 05:45
Marvell: The Market Is No Longer Trading On FY 2027
Seeking Alpha · 09/30 11:51
Marvel Biosciences Announces Closing of Private Placement For Up To $3.0 Million
Newsfile · 09/29 21:52
Marvel Biosciences announces non‑brokered private placement for up to $3M
Seeking Alpha · 09/17 21:29
More
About MBCOF
Marvel Biosciences Corp. is a Canada-based pre-clinical-stage pharmaceutical development biotechnology company. The Company develops new synthetic chemical derivatives of the original approved drug for the new disease indication. It has developed several new chemical entities, using synthetic chemical derivatives of known, off-patent drugs that inhibit the A2a adenosine receptor with application to neurological diseases (depression and anxiety, Alzheimer's, attention deficit hyperactivity disorder (ADHD)), and the non-neurological conditions of cancer and non-alcoholic steatohepatitis. The Company's lead compound, MB-204, is a fluorinated derivative of Istradefylline. The Company is engaged in developing MB-204 for diseases other than Parkinson's disease, specifically depression, Alzheimer’s Disease and liver fibrosis due to non-alcoholic steatohepatitis (NASH). Its wholly owned subsidiary is Marvel Biotechnology Inc.

Webull offers Marvel Biosciences Corp stock information, including OTCMQB: MBCOF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MBCOF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MBCOF stock methods without spending real money on the virtual paper trading platform.